AI-powered emergency rooms are transforming hospital care in India through intelligent triage, predictive diagnostics, and real-time clinical decision support, offering life-saving potential ... Sep 09
AI medical scribes offer Indian doctors a technology-driven way to reduce documentation burden, reclaim clinical time, and address the growing crisis of physician burnout ... Sep 08
... Mar 20
It is important to note that tofacitinib has not been approved or authorized for use by any regulatory authority worldwide for the treatment of COVID-... Jun 17
Pfizer Inc/BioNTech said according to a laboratory study, the South African variant of the coronavirus may reduce antibody protection from their vaccine by two-... Feb 18
In the US, gastric cancer is most frequently diagnosed in the advanced stage, with only approximately 5% of patients surviving beyond five years.... Jan 18
Farxiga could become the first SGLT2 inhibitor approved to treat patients with chronic kidney disease, with and without type-2 diabetes... Jan 06
Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk of disease recurrence or death by 80%... Dec 21
Abbott has launched its clip delivery system, a minimally invasive heart valve repair device to treat mitral regurgitation in India. ... Dec 18
MASITINIB DEMONSTRATED SIGNIFICANT EFFECT ON BOTH COGNITION, MEASURED WITH ADAS-COG, AND DAILY ACTIVITY, MEASURED WITH ADCS-ADL... Dec 16
The impact of the disease is significant, with breast cancer responsible for more than 137,000 deaths per year.... Dec 14
COPD is a progressive disease, which can cause obstruction of airflow in the lungs resulting in debilitating bouts of breathlessness and is the third leading ... Dec 14
... Nov 19
Clinical evidence for this device demonstrates safety and efficacy for people suffering from mitral regurgitation... Nov 18
If approved, Forxiga would become the first SGLT2 inhibitor indicated for heart failure with reduced ejection fraction in patients with and without type-2 diabetes... Oct 19
Scientists skeptic about antibodies theory and plasma therapy... Sep 08
The FDA granted evinacumab breakthrough therapy designation in 2017 for the treatment of hypercholesterolemia in patients with HoFH... Aug 13
Hydroxychloroquine has been broadly controlled to patients with Covid-19 without strong proof supporting its utilization... May 26
Adaptive Learning Course Now Available at No Cost to Health Professionals... Mar 11
Sequencers from UK to reach China to help quick surveillance of Coronavirus... Feb 01
-Advertisements-
.jpeg)
Thursday, October 08, 2026
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)